Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats. (Q44014663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Iván Izquierdo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Jaqueline N Picada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

João Antônio Pêgas Henriques

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rafael Roesler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

105-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Biochemical and toxicological properties of the oxidation products of catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Sensory and cognitive functions of the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Apomorphine for motor fluctuations and freezing in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

The up-and-down method for the determination of nociceptive thresholds in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

The effect of amantadine, l-DOPA, (+)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM sialylation state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Nefiracetam (DM-9384) reverses apomorphine-induced amnesia of a passive avoidance response: delayed emergence of the memory retention effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Apoptosis, neurotrophic factors and neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Cognitive deficits in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Oxidative stress and antioxidant therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Levodopa neurotoxicity: experimental studies versus clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Dose finding in the Ames Salmonella assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Toxic and protective effects of L-dopa on mesencephalic cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Guanosine impairs inhibitory avoidance performance in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Oxidative reactions and schizophrenia: a review-discussion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

Pharmacology and Neurochemistry of Apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Motor response following repeated apomorphine administration is reduced in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901553-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)01553-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044799%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference